❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Cancer Genetics ❭ Vacant positions ❭
Scroll to top

Home Institute for Cancer Research Dept. of Cancer Genetics

  • Computational Systems Medicine [Aittokallio]
  • Translational studies on solid tumours [Helland]
  • Genomic alterations in breast cancer [Russnes]
  • Breast tumor evolution [Sørlie]
  • Genetics staff list
  • KG Jebsen Centre for Breast Cancer Research
  • Project groups
  • Lab technology group
  • Publications
  • Vacant positions
  • News

Recent publications

Stålberg SM, Silwal-Pandit L, Hamfjord J, Nebdal DJH, Lehtiö J, Lingjærde OC, Skålhegg BS, Kure EH (2025)
Elevated KRAS protein level is associated with better survival in pancreatic cancer
BMC Cancer, 25 (1), 1080
DOI 10.1186/s12885-025-14461-w, PubMed 40596921

Pagui ECK, Brant SB, Svendsen K, Frigessi A, Helland Å, Thoresen S, Jonasson C (2025)
Comparative Effectiveness of Atezolizumab, Nivolumab and Pembrolizumab in Second-Line Treatment of Advanced Non-Small Cell Lung Cancer
Pharmacoepidemiol Drug Saf, 34 (7), e70181
DOI 10.1002/pds.70181, PubMed 40552731

Røssevold AH, Tekpli X, Lingjærde OC, Russnes HG, Vallon-Christersson J, Borgen E, Lømo J, Garred Ø, Dorraji E, Kristensen VN, Naume B, Kyte JA (2025)
High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis
Commun Med (Lond), 5 (1), 234
DOI 10.1038/s43856-025-00865-z, PubMed 40523912

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)